UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities
Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
September 16, 2019
DIGIRAD CORPORATION |
(Exact Name of Registrant as Specified in Its Charter) |
|
|
|
Delaware |
001-35947 |
33-0145723 |
(State or Other Jurisdiction
of Incorporation) |
(Commission
File Number) |
(IRS Employer
Identification No.) |
|
|
|
1048
Industrial Court,Suwanee, GA
|
30024 |
(Address of Principal Executive Offices) |
(Zip Code) |
Registrant’s Telephone Number, Including
Area Code: (858) 726-1600
Not Applicable |
(Former Name or Former Address, If Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
☐ Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class |
Trading Symbol(s) |
Name of Each Exchange on Which Registered |
Common Stock, par value $0.0001 per share |
DRAD |
NASDAQ Global Market |
Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share
|
DRADP |
NASDAQ Global Market
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if
the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01.
Regulation FD Disclosure.
Press Release
On September 16,
2019, Digirad Corporation (the “Company”) issued a press release regarding certain financial guidance for its fiscal
year ended December 31, 2020 (the “Guidance”), and which also described the primary tenets of the Company’s growth
strategy. A copy of the press release is furnished as Exhibit 99.1 hereto.
Investor Presentation
Pursuant to Regulation
FD, the Company hereby furnishes the presentation (the “Presentation”) that the Company will make available on or after
September 16, 2019, relating to the Company’s conversion into a diversified holding company, future acquisitions and the
Guidance. The Presentation is attached hereto as Exhibit 99.2 and is available on the Company’s website at http://ir.digirad.com/events-presentations.
The information
furnished by the Company pursuant to this item, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) or otherwise subject
to the liability of that section, and shall not be deemed to be incorporated by reference into any Company filing under the Securities
Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
Forward-Looking Statements
The
Securities and Exchange Commission encourages companies to disclose forward-looking information so that investors can better
understand a company’s future prospects and make informed investment decisions. This report contains forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this report that are
not statements of historical fact are hereby identified as “forward-looking statements” for the purpose of the
safe harbor provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. Forward-looking Statements include, without limitation, statements regarding (i) the plans and
objectives of management for future operations, including plans or objectives relating to acquisitions and related
integration, development of commercially viable products, novel technologies, and modern applicable services, (ii)
projections of income (including income/loss), EBITDA, earnings (including earnings/loss) per share, free cash flow (FCF),
capital expenditures, cost reductions, capital structure or other financial items, (iii) the future financial performance of
the Company or acquisition targets and (iv) the assumptions underlying or relating to any statement described above.
Moreover, forward-looking statements necessarily involve assumptions on the Company’s part. These forward-looking
statements generally are identified by the words “believe”, “expect”,
“anticipate”, “estimate”, “project”, “intend”, “plan”,
“should”, “may”, “will”, “would”, “will be”, “will
continue” or similar expressions. Such forward-looking statements are not meant to predict or guarantee actual results,
performance, events or circumstances and may not be realized because they are based upon the Company's current projections,
plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties
and other influences, many of which the Company has no control over. Actual results and the timing of certain events and
circumstances may differ materially from those described above as a result of these risks and uncertainties. Factors that may
influence or contribute to the inaccuracy of forward-looking statements or cause actual results to differ materially from
expected or desired results may include, without limitation, the substantial amount of debt of the Company and the
Company’s ability to repay or refinance it or incur additional debt in the future; the Company’s need for a
significant amount of cash to service and repay the debt and to pay dividends on the Company Preferred Stock; the
restrictions contained in the debt agreements that limit the discretion of management in operating the business; the length
of time associated with servicing customers; losses of significant contracts; disruptions in the relationship with third
party vendors; accounts receivable turnover; insufficient cash flows and resulting illiquidity; the Company's inability to
expand the Company's business; unfavorable changes in the extensive governmental legislation and regulations governing
healthcare providers and the provision of healthcare services and the competitive impact of such changes (including
unfavorable changes to reimbursement policies); high costs of regulatory compliance; the liability and compliance costs
regarding environmental regulations; the underlying condition of the technology support industry; the lack of product
diversification; development and introduction of new technologies and intense competition in the healthcare industry;
existing or increased competition; risks to the price and volatility of the Company’s Common Stock and Preferred Stock;
stock volatility and illiquidity; risks to preferred stockholders of not receiving dividends and risks to the Company’s
ability to pursue growth opportunities if the Company continues to pay dividends according to the terms of the Company
Preferred Stock; the Company’s ability to execute on its business strategy (including any cost reduction plans); the
Company’s failure to realize expected benefits of restructuring and cost-cutting actions; the Company’s ability
to preserve and monetize its net operating losses; risks associated with the Company’s possible pursuit of
acquisitions; the Company’s ability to consummate successful acquisitions and execute related integration, including to
successfully integrate ATRM’s operations and realize the synergies from the acquisition, as well as factors related to
the Company’s business (including ATRM) including economic and financial market conditions generally and economic
conditions in the Company’s markets; failure to keep pace with evolving technologies and difficulties integrating
technologies; system failures; losses of key management personnel and the inability to attract and retain highly qualified
management and personnel in the future; and the continued demand for and market acceptance of the Company’s services.
For a detailed discussion of cautionary statements and risks that may affect the Company’s future results of operations
and financial results, please refer to the Company’s filings with the Securities and Exchange Commission, including,
but not limited to, the risk factors in the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on
Form 10-Q. Furthermore, forward-looking statements speak only as of the date they are made. All forward-looking statements
are necessarily only estimates of future results, and there can be no assurance that actual results will not differ
materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Further, any
forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any
forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the
occurrence of unanticipated events.
Item 9.01.
Financial Statements and Exhibits
(d) Exhibits.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
DIGIRAD CORPORATION |
|
|
|
Date: September 16, 2019
|
By: |
/s/ Matthew G. Molchan |
|
|
|
Matthew G. Molchan
President and Chief Executive Officer
|
Exhibit 99.1
Digirad Corporation Announces Preliminary
Guidance for 2020
Anticipates growing revenues, earnings,
and cash flow while optimizing costs and capital optimization
Seeks additional attractive acquisition
opportunities
Suwanee, GA, September 16, 2019 –
Digirad Corporation (NASDAQ: DRAD; DRADP) (“Digirad” or the “Company”) converted into a diversified holding
company (“HoldCo”) following the September 10, 2019 acquisition of ATRM Holdings, Inc. (“ATRM”). Digirad
announced today preliminary guidance for 2020 and the primary tenets of its growth strategy.
HoldCo has three divisions*:
| · | Healthcare Imaging (Digirad
Health): designs, manufactures, and distributes diagnostic
medical imaging products and offers mobile healthcare services and solutions to healthcare providers (hospitals and physicians) |
| · | Building & Construction
(ATRM): services residential and commercial construction projects
by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products,
and supplies general contractors with building materials |
| · | Real Estate & Investment Management:
manages real estate assets (currently three manufacturing plants in Maine) and investment funds |
* For more information
download Digirad’s investor presentation at http://ir.digirad.com/events-presentations.
“We
are very excited to commence operations as a diversified holding company,” said Jeff Eberwein, Chairman of Digirad. “Under
this new structure, our objective is to maximize shareholder value over the long term through high-return internal investments
that promote revenue growth, operating efficiencies, and cash flow generation. We will also look for attractive acquisition opportunities
in two categories: bolt-on acquisitions for our existing platform companies as well as acquisitions that create new platform companies
for HoldCo.”
FY
2020 Guidance
For FY 2020, Digirad’s guidance
ranges are revenues of $130 million to $150 million, adjusted EBITDA (as defined below) of $10 million to $12 million, and
free cash flow (as defined below) of $7 million to $9 million. ($5 million to $7 million after preferred stock dividends).
Free cash flow will be used for debt reduction, internal growth initiatives, and acquisitions.
The HoldCo structure allows each division
to benefit from the use of a shared services center, which will handle corporate functions so that the management teams of the
operating businesses can focus on operations, growth, and bolt-on acquisition opportunities. The Company believes that this model
will result in lower costs and improved operating and financial performance going forward. It will also optimize the use of capital
and other internal resources.
Use of Non-GAAP
Financial Measures by Digirad Corporation
This Digirad news release presents the non-GAAP
financial measures “Adjusted EBITDA” (defined as “earnings before interest, taxes, depreciation, amortization
adjusted for stock-based compensation, and other one-time transaction costs such as merger and acquisitions, financing and etc.”)
and “Free Cash Flow” (defined as “net cash from operating activities excludes expenditures on purchases of property
and equipment, net of dispositions”). The most directly comparable measures for these non-GAAP financial measures are net
income and diluted net income per share. All figures based on Digirad guidance for 2019 and projections for 2020 for Digirad are
after conversion into a diversified holding company (“HoldCo”).
These non-GAAP financial measures are intended
to supplement the GAAP financial information by providing additional insight regarding results of operations of the Company. The
non-GAAP adjusted EBITDA financial measures used by the Company are intended to provide an enhanced understanding of our underlying
operational measures to manage the Company’s business, to evaluate performance compared to prior periods and the marketplace,
and to establish operational goals. Certain items are excluded from these non-GAAP financial measures to provide additional comparability
measures from period to period. These non-GAAP financial measures will not be defined in the same manner by all companies and may
not be comparable to other companies.
About Digirad Health
Digirad Health designs, manufactures, and
distributes diagnostic medical imaging products. Digirad Health operates in three businesses: Diagnostic Services, Mobile
Healthcare, and Diagnostic Imaging. The Diagnostic Services business offers imaging and monitoring services to healthcare providers
as an alternative to purchasing the equipment or outsourcing the job. The Mobile Healthcare business provides contract
diagnostic imaging, including computerized tomography (“CT”), magnetic resonance imaging (“MRI”), positron
emission tomography (“PET”), PET/CT, and nuclear medicine and healthcare expertise through a convenient mobile service.
The Diagnostic Imaging business develops, sells, and maintains solid-state gamma cameras.
About ATRM
ATRM manufactures modular housing units for
commercial and residential applications. ATRM operates in two businesses: (i) modular building manufacturing and (ii) structural
wall panel and wood foundation manufacturing, including building supply retail operations. The modular building manufacturing business
is operated by KBS Builders, the structural wall panel and wood foundation manufacturing segment is operated by EdgeBuilder, and
the retail building supplies are sold through Glenbrook Lumber. KBS Builders, EdgeBuilder and Glenbrook Lumber are wholly-owned
subsidiaries of ATRM.
Forward-Looking Statements
“Safe Harbor”
Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this presentation that are not statements
of historical fact are hereby identified as “forward-looking statements” for the purpose of the safe harbor provided
by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking
Statements include, without limitation, statements regarding (i) the plans and objectives of management for future operations,
including plans or objectives relating to acquisitions and related integration, development of commercially viable products, novel
technologies, and modern applicable services, (ii) projections of income (including income/loss), EBITDA, earnings (including earnings/loss)
per share, free cash flow (FCF), capital expenditures, cost reductions, capital structure or other financial items, (iii) the future
financial performance of Digirad Corporation (“Digirad,” “DRAD” or the “Company”) or acquisition
targets and (iv) the assumptions underlying or relating to any statement described above. Moreover, forward-looking statements
necessarily involve assumptions on the Company’s part. These forward-looking statements generally are identified by the words
“believe”, “expect”, “anticipate”, “estimate”, “project”, “intend”,
“plan”, “should”, “may”, “will”, “would”, “will be”, “will
continue” or similar expressions. Such forward-looking statements are not meant to predict or guarantee actual results, performance,
events or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives,
beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many
of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially
from those described above as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy
of forward-looking statements or cause actual results to differ materially from expected or desired results may include, without
limitation, the substantial amount of debt of the Company and the Company’s ability to repay or refinance it or incur additional
debt in the future; the Company’s need for a significant amount of cash to service and repay the debt and to pay dividends
on the Company Preferred Stock; the restrictions contained in the debt agreements that limit the discretion of management in operating
the business; the length of time associated with servicing customers; losses of significant contracts; disruptions in the relationship
with third party vendors; accounts receivable turnover; insufficient cash flows and resulting illiquidity; the Company's inability
to expand the Company's business; unfavorable changes in the extensive governmental legislation and regulations governing healthcare
providers and the provision of healthcare services and the competitive impact of such changes (including unfavorable changes to
reimbursement policies); high costs of regulatory compliance; the liability and compliance costs regarding environmental regulations;
the underlying condition of the technology support industry; the lack of product diversification; development and introduction
of new technologies and intense competition in the healthcare industry; existing or increased competition; risks to the price and
volatility of the Company’s Common Stock and Preferred Stock; stock volatility and illiquidity; risks to preferred stockholders
of not receiving dividends and risks to the Company’s ability to pursue growth opportunities if the Company continues to
pay dividends according to the terms of the Company Preferred Stock; the Company’s ability to execute on its business strategy
(including any cost reduction plans); the Company’s failure to realize expected benefits of restructuring and cost-cutting
actions; the Company’s ability to preserve and monetize its net operating losses; risks associated with the Company’s
possible pursuit of acquisitions; the Company’s ability to consummate successful acquisitions and execute related integration,
including to successfully integrate ATRM’s operations and realize the synergies from the acquisition, as well as factors
related to the Company’s business (including ATRM) including economic and financial market conditions generally and economic
conditions in the Company’s markets; failure to keep pace with evolving technologies and difficulties integrating technologies;
system failures; losses of key management personnel and the inability to attract and retain highly qualified management and personnel
in the future; and the continued demand for and market acceptance of the Company’s services. For a detailed discussion of
cautionary statements and risks that may affect the Company’s future results of operations and financial results, please
refer to the Company’s filings with the Securities and Exchange Commission, including, but not limited to, the risk factors
in the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. This presentation reflects management’s
views as of the date presented.
All forward-looking
statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ
materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Further, any forward-looking
statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement
to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated
events.
Non-GAAP Financial
Measures: The information provided herein includes certain non-GAAP financial measures. These non-GAAP financial measures are
intended to supplement the GAAP financial information by providing additional insight regarding results of operations of the Company.
The non-GAAP adjusted EBITDA financial measures used by the Company are intended to provide an enhanced understanding of our underlying
operational measures to manage the Company’s business, to evaluate performance compared to prior periods and the marketplace,
and to establish operational goals. Certain items are excluded from these non-GAAP financial measures to provide additional comparability
measures from period to period. These non-GAAP financial measures will not be defined in the same manner by all companies and may
not be comparable to other companies.
Specifically, this presentation presents the
non-GAAP financial measures “Adjusted EBITDA” (defined as “earnings before interest, taxes, depreciation, amortization
adjusted for stock-based compensation, and other one-time transaction costs such as merger and acquisitions, financing and etc.”)
and “Free Cash Flow” (defined as “net cash from operating activities excludes expenditures on purchases of property
and equipment, net of dispositions”). The most directly comparable measures for these non-GAAP financial measures are net
income and diluted net income per share. All future figures based on guidance after conversion into a diversified holding company
(“HoldCo”).
For more information contact: |
|
Digirad Corporation |
Investor Relations |
Chairman of the Board |
The Equity Group |
Jeff Eberwein |
Lena Cati |
203-489-9501 |
212-836-9611 |
ir@digirad.com |
lcati@equityny.com |
This regulatory filing also includes additional resources:
ex992to8k09271004_09162019.pdf
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Sep 2023 to Sep 2024